A citation-based method for searching scientific literature

Sivaramakrishna Rachakonda, Jörg D Hoheisel, Rajiv Kumar. Int J Cancer 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
Nancy E Thomas, Klaus J Busam, Lynn From, Anne Kricker, Bruce K Armstrong, Hoda Anton-Culver, Stephen B Gruber, Richard P Gallagher, Roberto Zanetti, Stefano Rosso,[...]. J Clin Oncol 2013
166
50

Telomerase and CD4 T Cell Immunity in Cancer.
Magalie Dosset, Andrea Castro, Hannah Carter, Maurizio Zanetti. Cancers (Basel) 2020
7
50

Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.
Caroline Laheurte, Jeanne Galaine, Laurent Beziaud, Magalie Dosset, Jerome Kerzerho, Claire Jacquemard, Béatrice Gaugler, Christophe Ferrand, Anne Dormoy, François Aubin,[...]. Oncoimmunology 2016
17
50

Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.
Charlée Nardin, Caroline Laheurte, Eve Puzenat, Laura Boullerot, Mélanie Ramseyer, Amélie Marguier, Marion Jacquin, Yann Godet, François Aubin, Olivier Adotevi. J Invest Dermatol 2021
1
100

Creation of human tumour cells with defined genetic elements.
W C Hahn, C M Counter, A S Lundberg, R L Beijersbergen, M W Brooks, R A Weinberg. Nature 1999
50

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.
Suzanne L Topalian, Janis M Taube, Robert A Anders, Drew M Pardoll. Nat Rev Cancer 2016
50

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.
Yann Godet, Elizabeth Fabre, Magalie Dosset, Michele Lamuraglia, Emeline Levionnois, Patrice Ravel, Nadine Benhamouda, Aurélie Cazes, Françoise Le Pimpec-Barthes, Beatrice Gaugler,[...]. Clin Cancer Res 2012
64
50

Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Josh Lewis Stern, Grace Hibshman, Kevin Hu, Sarah E Ferrara, James C Costello, William Kim, Pablo Tamayo, Thomas R Cech, Franklin W Huang. Mol Cancer Res 2020
9
50


MC1R germline variants confer risk for BRAF-mutant melanoma.
Maria Teresa Landi, Jürgen Bauer, Ruth M Pfeiffer, David E Elder, Benjamin Hulley, Paola Minghetti, Donato Calista, Peter A Kanetsky, Daniel Pinkel, Boris C Bastian. Science 2006
236
50

Gene Expression Integration into Pathway Modules Reveals a Pan-Cancer Metabolic Landscape.
Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Miguel A Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell-Caballero, Joaquin Dopazo. Cancer Res 2018
20
50

Red Hair, Light Skin, and UV-Independent Risk for Melanoma Development in Humans.
Elisabeth M Roider, David E Fisher. JAMA Dermatol 2016
13
50


Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
Reza Ghiasvand, Trude E Robsahm, Adele C Green, Corina S Rueegg, Elisabete Weiderpass, Eiliv Lund, Marit B Veierød. JAMA Dermatol 2019
25
50


Actionable pathways: interactive discovery of therapeutic targets using signaling pathway models.
Francisco Salavert, Marta R Hidago, Alicia Amadoz, Cankut Çubuk, Ignacio Medina, Daniel Crespo, Jose Carbonell-Caballero, Joaquín Dopazo. Nucleic Acids Res 2016
15
50

Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations.
Erik A Williams, Meagan Montesion, Nikunj Shah, Radwa Sharaf, Dean C Pavlick, Ethan S Sokol, Brian Alexander, Jeff Venstrom, Julia A Elvin, Jeffrey S Ross,[...]. Mod Pathol 2020
7
50

Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.
Laura Calomarde-Rees, Rosario García-Calatayud, Celia Requena Caballero, Esperanza Manrique-Silva, Víctor Traves, Zaida García-Casado, Virtudes Soriano, Rajiv Kumar, Eduardo Nagore. JAMA Dermatol 2019
13
50

Melanoma: What do all the mutations mean?
Elizabeth J Davis, Douglas B Johnson, Jeffrey A Sosman, Sunandana Chandra. Cancer 2018
46
50

VarSome: the human genomic variant search engine.
Christos Kopanos, Vasilis Tsiolkas, Alexandros Kouris, Charles E Chapple, Monica Albarca Aguilera, Richard Meyer, Andreas Massouras. Bioinformatics 2019
439
50

The genomic landscape of cutaneous melanoma.
Tongwu Zhang, Ken Dutton-Regester, Kevin M Brown, Nicholas K Hayward. Pigment Cell Melanoma Res 2016
84
50

NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.
Helena Cirenajwis, Martin Lauss, Henrik Ekedahl, Therese Törngren, Anders Kvist, Lao H Saal, Håkan Olsson, Johan Staaf, Ana Carneiro, Christian Ingvar,[...]. Mol Oncol 2017
50
50

Determinants of BRAF mutations in primary melanomas.
Janet L Maldonado, Jane Fridlyand, Hetal Patel, Ajay N Jain, Klaus Busam, Toshiro Kageshita, Tomomichi Ono, Donna G Albertson, Dan Pinkel, Boris C Bastian. J Natl Cancer Inst 2003
465
50

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
David C Gibbs, Irene Orlow, Jennifer I Bramson, Peter A Kanetsky, Li Luo, Anne Kricker, Bruce K Armstrong, Hoda Anton-Culver, Stephen B Gruber, Loraine D Marrett,[...]. J Natl Cancer Inst 2016
21
50

High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes.
Marta R Hidalgo, Cankut Cubuk, Alicia Amadoz, Francisco Salavert, José Carbonell-Caballero, Joaquin Dopazo. Oncotarget 2017
31
50

TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Juan J Andrés-Lencina, Sivaramakrishna Rachakonda, Zaida García-Casado, Nalini Srinivas, Alexander Skorokhod, Celia Requena, Virtudes Soriano, Rajiv Kumar, Eduardo Nagore. Int J Cancer 2019
24
50

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Kai Kang, Fucun Xie, Jinzhu Mao, Yi Bai, Xiang Wang. Front Oncol 2020
16
50

Melanoma.
Dirk Schadendorf, David E Fisher, Claus Garbe, Jeffrey E Gershenwald, Jean-Jacques Grob, Allan Halpern, Meenhard Herlyn, Michael A Marchetti, Grant McArthur, Antoni Ribas,[...]. Nat Rev Dis Primers 2015
236
50

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.
Roy Rabbie, Peter Ferguson, Christian Molina-Aguilar, David J Adams, Carla D Robles-Espinoza. J Pathol 2019
63
50

Genetic basis for clinical response to CTLA-4 blockade in melanoma.
Alexandra Snyder, Vladimir Makarov, Taha Merghoub, Jianda Yuan, Jesse M Zaretsky, Alexis Desrichard, Logan A Walsh, Michael A Postow, Phillip Wong, Teresa S Ho,[...]. N Engl J Med 2014
50

TERT promoter mutations in telomere biology.
Barbara Heidenreich, Rajiv Kumar. Mutat Res Rev Mutat Res 2017
86
50

p53 expression and risk factors for cutaneous melanoma: a case-control study.
D C Whiteman, P G Parsons, A C Green. Int J Cancer 1998
100
50

Different genetic mechanisms mediate spontaneous versus UVR-induced malignant melanoma.
Blake Ferguson, Herlina Y Handoko, Pamela Mukhopadhyay, Arash Chitsazan, Lois Balmer, Grant Morahan, Graeme J Walker. Elife 2019
10
50

Melanoma: from mutations to medicine.
Hensin Tsao, Lynda Chin, Levi A Garraway, David E Fisher. Genes Dev 2012
328
50

Cutaneous melanoma primary site is linked to nevus density.
Alejandro Martin-Gorgojo, Marta Llinares, Amaya Virós, Celia Requena, Zaida Garcia-Casado, Víctor Traves, Rajiv Kumar, Eduardo Nagore. Oncotarget 2017
5
50


UVB mutagenesis differs in Nras- and Braf-mutant mouse models of melanoma.
Robert L Bowman, Rebecca C Hennessey, Tirzah J Weiss, David A Tallman, Emma R Crawford, Brandon M Murphy, Amy Webb, Souhui Zhang, Krista Md La Perle, Craig J Burd,[...]. Life Sci Alliance 2021
1
100


KEGG: Kyoto Encyclopedia of Genes and Genomes.
H Ogata, S Goto, K Sato, W Fujibuchi, H Bono, M Kanehisa. Nucleic Acids Res 1999
50

RAC1 and melanoma.
Ruth Halaban. Clin Ther 2015
28
50

BRAF mutations are common somatic events in melanocytic nevi.
Rajiv Kumar, Sabrina Angelini, Erna Snellman, Kari Hemminki. J Invest Dermatol 2004
159
50

An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Devarati Mitra, Xi Luo, Ann Morgan, Jin Wang, Mai P Hoang, Jennifer Lo, Candace R Guerrero, Jochen K Lennerz, Martin C Mihm, Jennifer A Wargo,[...]. Nature 2012
270
50

Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma.
J Cho, S Y Kim, Y J Kim, M H Sim, S T Kim, N K D Kim, K Kim, W Park, J H Kim, K-T Jang,[...]. Clin Transl Oncol 2017
8
50


Carcinogen susceptibility is regulated by genome architecture and predicts cancer mutagenesis.
Pablo E García-Nieto, Erin K Schwartz, Devin A King, Jonas Paulsen, Philippe Collas, Rafael E Herrera, Ashby J Morrison. EMBO J 2017
36
50


Pathways and therapeutic targets in melanoma.
Emma Shtivelman, Michael Q A Davies, Patrick Hwu, James Yang, Michal Lotem, Moshe Oren, Keith T Flaherty, David E Fisher. Oncotarget 2014
141
50

Distinct sets of genetic alterations in melanoma.
John A Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N Patel, Klaus J Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E LeBoit,[...]. N Engl J Med 2005
50


MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions.
Hiroki Sato, Adam J Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa, Daisuke Kubota, Allan J W Lui, Besnik Qeriqi, Marissa Mattar,[...]. Clin Cancer Res 2020
10
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.